LCTX

LCTX Net Income Growth

21.14%TTM

Period ending:

LCTX TTM Net Income YoY %%
LCTX TTM Net Income YoY %515.05%-414.56%
1993-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

LCTX net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 129 observations from Dec 31, 1993 to Jun 30, 2026.

Lineage Cell Therapeutics, Inc. Common Stock Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
21.144%
-296.1866%
-241.4101%
-236.4179%
-69.1404%
31.4931%
13.3901%
12.8073%
-9.8211%
-0.416%
18.2202%
52.841%
56.5284%
51.6144%
38.9241%
-307.7449%
-324.5977%
-256.271%
-108.3249%
55.8407%
66.7706%
77.0002%
-76.3515%
47.9427%
-215.642%
-204.4841%
74.5401%
28.4945%
124.7663%
142.8184%
-130.2263%
-255.6504%
-296.6374%
-232.8651%
-159.5232%
85.9511%
425.0905%
285.6164%
171.5437%
157.2325%
49.3123%
-39.7943%
-28.6759%
3.1814%
16.31%
12.9704%
16.9304%
-50.1278%
-76.0517%
-83.1413%
-104.8426%
-46.064%
-34.478%
-31.7169%
-27.9908%
-44.6221%
-27.8003%
-38.3557%
-49.283%
-110.2915%
-166.8601%
-168.5975%
-117.9759%
16.0748%
-1.676%
-2.3755%
-36.0469%
-219.6965%
-235.3992%
-254.5358%
-162.8921%
-70.6606%
-3.8716%
29.8864%
22.8676%
24.5935%
21.1818%
-6.2682%
10.1063%
7.339%
5.4613%
15.8196%
32.7704%
31.9876%
6.5414%
17.6513%
-77.1064%
-63.261%
18.8744%
8.8511%
38.7657%
28.6201%
5.0957%
13.7886%
20.9116%
33.164%
30.6436%
26.4438%
26.9617%
24.8211%

Compare net income growth

Other companies in —. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All LCTX financial metrics · LCTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.